(vianews) - boiron (boi.pa) is among this list of stock assets with the highest dividend rate and return on equity on the healthcare sector.
| financial asset | price | forward dividend yield | return on equity |
|---|---|---|---|
| boiron (boi.pa) | €33.62 | 3.76% | 7.15% |
| contextvision (contx.ol) | kr5.84 | 3.46% | 61.1% |
several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. boiron (boi.pa)
3.76% forward dividend yield and 7.15% return on equity
boiron sa manufactures and sells homeopathic medicines in france, rest of europe, north america, and internationally. the company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. it also provides homeopathic specialties comprising oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; stodal and stodaline for treating coughs; arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; camilia for the treatment of teething problems for babies; sédatif pc to treat anxiety and emotional, and minor sleep disorders; coryzalia for the treatment of cold symptoms and rhinitis; homéoptic to treat eye discomfort and irritation due to various causes for adults and children; homéovox for vocal disorders; homéoplasmine for treating irritated skin and redness; varésol to treat symptoms of chickenpox; and arnicare arthritis for use in the treatment of benign trauma pain. in addition, it offers dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; covid self-tests and rapid antigenic tests; labiameo, that used to treat outbreaks of localized cold sores; and convameo to treat physical and mental asthenia. the company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. boiron sa was founded in 1932 and is headquartered in messimy, france.
earnings per share
as for profitability, boiron has a trailing twelve months eps of €2.74.
pe ratio
boiron has a trailing twelve months price to earnings ratio of 12.27. meaning, the purchaser of the share is investing €12.27 for every euro of annual earnings.
return on equity
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.15%.
revenue growth
year-on-year quarterly revenue growth declined by 8.7%, now sitting on 493.25m for the twelve trailing months.
more news about boiron.
2. contextvision (contx.ol)
3.46% forward dividend yield and 61.1% return on equity
contextvision ab (publ), a medical technology software company, provides image analysis and imaging for medical systems in asia, europe, and america. the company offers image enhancement software for 2d/3d/4d ultrasound, radiography, magnetic resonance imaging (mri), and veterinary uses. its products include rivent that offers image enhancement and visualization solutions for ultrasound systems for women's health, general imaging, cardiovascular, and point of care applications; rivent mobile, a 2d image enhancement product for handheld units; and rivent 3d, an image enhancement solution for 3d ultrasound. the company also provides altumira/altumira plus, an artificial intelligence-powered image enhancement product for digital radiography; and orthopedic package for orthopedic imaging. in addition, it offers gopview mri2plus, an image enhancement solution for mri. contextvision ab (publ) was founded in 1983 and is headquartered in stockholm, sweden.
earnings per share
as for profitability, contextvision has a trailing twelve months eps of kr0.42.
pe ratio
contextvision has a trailing twelve months price to earnings ratio of 13.9. meaning, the purchaser of the share is investing kr13.9 for every norwegian krone of annual earnings.
return on equity
the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 61.1%.
yearly top and bottom value
contextvision's stock is valued at kr5.84 at 02:30 est, way under its 52-week low of kr7.80.
dividend yield
as stated by morningstar, inc., the next dividend payment is on nov 2, 2023, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 3.46%.
sales growth
contextvision's sales growth for the current quarter is 29.8%.
stock price classification
according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, contextvision's stock is considered to be oversold (<=20).
more news about contextvision.